Thoracic Tumours: Essentials for Clinicians, 2nd edition

2019 ESMO Essentials for Clinicians Thoracic Tumours

Download the complete book (ESMO members only)

Thoracic Tumours: Essentials for Clinicians, 2nd edition is intended primarily to be read by young oncologists (residents at the beginning of their career) and provides the reader with the essential information or ‘What every oncologist should know’. In addition to more common cancers such as non-small cell lung cancer, the title also discusses rarer tumour types, such as extragonadal germ cell tumours. This second edition introduces new chapters on targeted therapy for oncogene-addicted tumours and immunotherapy for advanced NSCLC. In addition to the essentials, the book also introduces more advanced knowledge for those who wish to explore the topic further.

As with all titles in the Essentials for Clinicians series, the subject is presented in a very visual and didactic format to enable the reader to easily assimilate the information and includes revision questions to test the acquired knowledge.

The content of this Essentials for Clinicians on Thoracic Tumours is restricted to ESMO members only.

Part A: What Every Oncologist Should Know

Chapter 1 – Epidemiology, pathogenesis and risk factors

Chapter 2 – Prevention and screening of lung cancer

Chapter 3 – Diagnosing lung cancer

Chapter 4 – Histopathological and molecular characterisation of lung cancer

Chapter 5 – Principles of surgery of non-small cell lung cancer

Chapter 6 – Principles of radiotherapy of thoracic tumours

Chapter 7 – Adjuvant and neoadjuvant therapy

Chapter 8 – Treatment of metastatic non-small cell lung cancer

Chapter 9 – Treatment of small cell lung cancer: chemotherapy and radiotherapy

Chapter 10 – Targeted therapy for oncogene-addicted metastatic non-small cell lung cancer

Chapter 11 – Immunotherapy for thoracic malignancies: Part A - Non-small cell lung cancer

B. More advanced knowledge

Chapter 12 – Malignant pleural mesothelioma

Chapter 13 – Thymic malignancies

Chapter 14 – Neuroendocrine tumours of lung origin

Chapter 15 – Immunotherapy for thoracic malignancies: Part B - Small cell lung cancer and mesothelioma

Chapter 16 – Emerging targets and new agents in lung cancer

Appendices